top of page


Updated: Aug 17, 2021

In this issue of GOLD, we look back at the pharmaceutical industry’s top news stories from the past few months, covering the latest COVID-19 developments, the most prominent drug approvals, and the standout departures and appointments.

21 April

Novartis’ first-of-its-kind MS therapy Kesimpta wins NICE backing

29 April

Simon Stevens, CEO, NHS England will step down after 7 years, at the end of July

03 May

AstraZeneca’s Farxiga achieves FDA approval for use in treating chronic kidney disease

04 May

The ABPI appoints Ben Osborn as their new president

10 May

Sinopharm’s COVID-19 vaccine is approved for emergency use by WHO

11 May

Pfizer and BioNTech’s COVID-19 vaccine first to be approved by FDA for use in children aged 12–15

21 May

Janssen’s genetically defined non-small cell lung cancer therapy Rybrevant wins FDA approval

22 May

Takeda’s dengue fever vaccine secures positive long-term safety and efficacy results

25 May

Moderna’s COVID-19 vaccine proves to be highly effective in adolescents

28 May

The MHRA approves Johnson and Johnson’s one-dose COVID-19 vaccine for use in the UK

02 June

Sinovac’s COVID-19 vaccine is approved for emergency use by WHO

07 June

Eisai and Biogen’s Alzheimer’s drug Aducanumab achieves landmark approval by FDA

bottom of page